Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
Sales | 1,067 | 12,037 | 1,589 | 847 | 943 |
Cost of Goods | 610 | 0 | 585 | 497 | 571 |
Gross Profit | 1,370 | 12,037 | 1,004 | 284 | 250 |
Operating Expenses | 7,300 | 0 | 6,804 | 0 | 0 |
Operating Income | -6,843 | 12,037 | -5,800 | 350 | 372 |
Interest Expense | 50 | 0 | 55 | 55 | 54 |
Other Income | 903 | 0 | 0 | -5,201 | -4,610 |
Pre-tax Income | -5,990 | 12,037 | -5,855 | -4,905 | -4,292 |
Net Income Continuous | -6,045 | 1,880 | -5,855 | -4,905 | -4,292 |
Net Income Discontinuous | 54 | 0 | 0 | 0 | 0 |
Net Income | $-5,991 | $1,880 | $-5,855 | $-4,905 | $-4,292 |
EPS Basic Total Ops | -2.12 | 0.64 | -2.28 | -2.60 | -2.48 |
EPS Basic Continuous Ops | -2.14 | 0.66 | -2.27 | -2.59 | -2.49 |
EPS Basic Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
EPS Diluted Total Ops | -2.12 | 0.60 | -2.28 | -2.60 | -2.48 |
EPS Diluted Continuous Ops | -2.14 | 0.61 | -2.27 | -2.59 | -2.49 |
EPS Diluted Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
EBITDA(a) | $-6,733 | $12,325 | $-5,800 | $350 | $372 |